DG Innovate PLC Further re Director Subscriptions

RNS Number : 8659M

DG Innovate PLC

20 November 2024

 

20 November 2024

DG Innovate plc

 

("DG Innovate", "DGI" or the "Company")

 

Further re Director Subscriptions

 

Total Voting Rights

 

DG Innovate plc (LSE: DGI), the advanced research and development company developing pioneering solutions in sustainable mobility and energy storage, announces, further to the Company's announcement made on 16 October 2024, that admission of the 286,666,667 Directors' Subscription Shares to the Official List and to trading on the Main Market is expected to occur at 8.00 a.m. on 22 November 2024 ("Admission").

 

Total Voting Rights

 

Upon Admission, the Company's issued share capital will consist of 12,187,984,954 Ordinary Shares with one voting right each. The Company holds 357,142 Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company will be 12,187,627,812. With effect from Admission, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Capitalised terms used but not defined in this announcement have the same meanings as set out in the announcement that was published by the Company at 7.00 a.m. on 16 October 2024.

 

Enquiries:

 

DG innovate plc Peter Bardenfleth-Hansen (CEO) Jack Allardyce (CFO)		C/O IFC
IFC Advisory (Investor Relations) Tim Metcalfe Zach Cohen		020 3934 6630
Grant Thornton UK LLP (Financial Adviser) Samantha Harrison Jamie Barklem Ciara Donnelly		020 7383 5100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

FURGPGRAGUPCGMB